A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) A61K 31/135 (2006.01) A61K 38/20 (2006.01)
Patent
CA 2180193
Cell mediated immunity against persistent viral infection in a host is potentiated by administering to the host an effective amount of at least one antiestrogen capable of enhancing cytotoxic T lymphocytes in the host, such as a triphenylethylene tamoxifen, particularly tamoxifen or toremifene. This administration leads to the elimination of all infected cells and to the complete clearance of virus and virus induced tumor cells from the body, leaving protective cell mediated immunity. This therapy requires MHC restricted virus specific CTLs which then will kill virus infected very specifically, which may be initially present or formed in vivo or in vitro. The effect of the antiestrogen may be enhanced by the use of interferons optionally with indomethacin.
Baral Edward
Berczi Istvan
Dawood Magdy
Nagy Eva
Manitoba Cancer Treatment & Research Foundation
Sim & Mcburney
University Of Manitoba
LandOfFree
Enhancing host immunity against viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancing host immunity against viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancing host immunity against viral infections will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1884993